type 2 diabetes
Item
type 2 diabetes;
boolean
C0011860 (UMLS CUI [1])
antidiabetic agents
Item
types and doses of antidiabetic agents had been unchanged for four weeks before the postprandial study;
boolean
C0935929 (UMLS CUI [1])
nonsmokers
Item
nonsmokers;
boolean
C0337672 (UMLS CUI [1])
comorbidity
Item
no prior cardiovascular disease, hepatic and renal diseases, or other diseases influencing fat absorption;
boolean
C0009488 (UMLS CUI [1])
gastro-enteral surgery
Item
no previous history of gastro-enteral surgery;
boolean
C0543467 (UMLS CUI [1])
dietary fat provided energy
Item
dietary fat provided energy less than 35% in last two weeks;
boolean
C0012155 (UMLS CUI [1])
medications or vitamins known to affect plasma lipids
Item
no use of medications or vitamins known to affect plasma lipids;
boolean
C1278073 (UMLS CUI [1])
ability to hold hypoglycemic drugs on the day of the study until postprandial tests are completed
Item
ability to hold hypoglycemic drugs on the day of the study until postprandial tests are completed;
boolean
C0020616 (UMLS CUI [1])
informed consent
Item
ability to provide verbal informed consent to participate.
boolean
C0021430 (UMLS CUI [1])
females with menstrual cycles
Item
females with menstrual cycles
boolean
C0279752 (UMLS CUI [1])